Vanguard stopped buying Russian stocks. AmerisourceBergen said it’s still supporting patients in drug trials there
Vanguard is the latest in a long line of money managers backing out of Russian markets. Pharmaceutical distributor AmerisourceBergen says its focus is on providing access to medical products.
